by Alex McGuire
There are 14 upcoming IPOs this week, marking the busiest five-day stretch for IPOs since last July.
The most anticipated offering this week is Bojangles' Inc. (Nasdaq: BOJA). It will be the second restaurant IPO this year behind Shake Shack Inc. (NYSE: SHAK).
Here's a look at the rest of the upcoming IPOs this week...
McDonald's boss Steve Easterbrook's turnaround plan failed to convince many investors that the company has found a coherent direction.
by
Just what is the government hiding from us? It's a question on many people's minds, though conspiracy theorists are the ones doing the asking.
Since they know full well the government isn't going to respond with a litany of honest answers, they have to do their own research.
Here are four of the most investigated rumored cover-ups...
by David Zeiler
The Greek debt crisis is bigger than the fate of a single gold mine, but this is a story about how political ideology often trumps common sense.
Greece should be doing everything it can to prop up its economy as it seeks to avoid a financial disaster.
But the leftist Syriza party, elected to power in January, has done everything it can to shut down a lucrative gold mine run by Canadian gold miner Eldorado Gold Corp. (NYSE: EGO).They say it's about protecting the environment.
But there's more to it than that - and it defies logic...
The biotech market has sold off last week, with the Nasdaq Biotechnology Index dropping 6.4% since April 23. And because of that, some of the best biotech stocks have dipped as well.
Now, investors are wondering if they should take their money to the sideline. But Money Morning's Bioscience Investing specialist Ernie Tremblay says this type of move is normal for the biotech market.
Here are three stocks we're recommending now that they're trading at discounted prices...
DJIA futures for Monday, May 4, forecasted a 56-point increase over Friday's close.
On Friday, markets jumped more than 183 points on news that monthly consumer sentiment increased. U.S. automotive vehicle sales in April were higher than expected for manufacturers like General Motors Company (NYSE: GM) and Ford Motor Company (NYSE: F).
Here's everything else investors need to know about the stock market today...
by Tom Gentile
In the world of precious metals, silver is considered the "Poor Man's Gold."
Anyone who believes this nonsense will stay away from investing in silver for all the wrong reasons.
With the S&P 500 pushing resistance once again at 2,100, perhaps it's time to visit the land of the contrarian trader, for as the saying goes, as the stock market falls, the precious metals markets rise.
T.S. Eliot must roll over in his grave every time some smart-alecky financial writer says that "April is the cruelest month."
Having to hear the anti-intellectual elite pretend to have read, never mind think they have the remotest understanding of those words or what follows in one of the most complex literary works of the 20th century is galling enough. But hearing that over-used phrase misused to excuse more underperformance and bad policy is flat-out nauseating.
April 2015 was only cruel to those who remain wedded to the idea that markets are rational, trends move in straight lines, and policy makers have the remotest clue of what they are doing.
If all you've been hearing regarding China recently is noise about its economic slowdown, you need to find a better news source.
Investors need to stop worrying over China's long-expected gradual slowdown.
Do so and you likely will see, as my guest today does, the long-term growth ahead for key tech sectors in the world's most populous nation.
by Jim Bach
Euro-dollar parity is still coming. Don’t be fooled by this sudden rebound.
The fundamentals support a fast dive to euro-dollar parity. But the technical traders simply won’t allow it to fall to those levels so quickly.
Here’s why euro-dollar parity will still happen, even if there are some snags on the way down…
